[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Editorial Board::
Executive Members::
Instruction to Authors::
Peer Review::
Articles Archive::
Indexing Databases::
Contact Us::
Site Facilities::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 20, Issue 1 (3-2018) ::
J Gorgan Univ Med Sci 2018, 20(1): 22-28 Back to browse issues page
Effect of multi-wall carbon nanotubes toxicity on kidney function and tissue in rats
Zahra Poormohammad Matouri1 , Ali Noori * 2
1- M.Sc in Animal Physiology, Department of Biology, Falavarjan Branch, Islamic Azad University, Isfahan, Iran
2- Assistant Professor, Department of Biology, Falavarjan Branch, Islamic Azad University, Isfahan, Iran. alinoori55@gmail.com , alinoori55@gmail.com
Abstract:   (28211 Views)
Background and Objective: The unique properties of carbon nanotubes have been used for medical, biological and industrial applications, but it simultaneously exposure to humans and organisms poses a potential for toxic effects on human health and the environment. This study was done to evaluate the effect of multi-wall carbon nanotubes toxicity on kidney function and tissue in rats.
Methods: In this experimental study, 50 mature female Wistar rats were allocated into five groups including: control and experimental groups with dosage of 2.5, 5, 10, 20 mg/kg/bw, respectively. Animals in control group were received physiological saline and Tween.Animals in treatment groups were received 2.5, 5, 10, 20 mg/kg/bw of multi-wall carbon nanotubes functionalized with carboxylic group with diameter less than 8 nm and length 30 micrometers in 8 steps in one day intraperitoneally. Blood samples were conducted in two phases: one day after the last injection and 20 days after the last injection. Urea, uric acid, creatinine and malondialdehyde levels were measured in blood serum. Tissue samples were provided by preparing histological sections of kidney in each group and stain with hematoxylin-eosin. The tissue structure of the kidney was examined by optical microscopy.
Results: In the first stage (one day after the last injection), only the amount of uric acid at concentrations of 2.5 and 5 mg/kg significantly reduced in comparison with controls and other treated groups, respectively (P<0.05). There were no significant changes in the level of other biochemical factors in compared to the control. However, 20 days after the last injection, significant reduction in the level of uric acid and urea was observed in 2.5, 5, 10, 20 mg/kg/bw of multi-wall carbon nanotubes in compared to the control group, although significant reduction in creatinine was seen in dosages of 5 and 10 mg/kg/bw of multi-wall carbon nanotubes in compared to controls (P<0.05). Histological studies showed altrations in trated groups including  accumulation of hyaline-like substances derived from the activity of eosinophils and accumulation of inflammatory cells (basophils and neutrophils) in the cortical and medula of the kidney, glomerular degeneration, Bowman capsule dilatation and degeneration of  proximal tube wall in the renal cortex which  these alterations  were dose-dependent.
Conclusion: Multi-wall carbon nanotubes functionalized with carboxyl groups even in low dosage (2.5 mg/kg) and after 20 days of injection cause toxicity in tissue structure and kidney function.
Keywords: Multi-Walled Carbon Nanotubes, Kidney, Tissue, Malondialdehyde, Uric acid
Full-Text [PDF 403 kb] [English Abstract]   (12581 Downloads) |   |   Abstract (HTML)  (7887 Views)  
Type of Study: Original Articles | Subject: Medical Biotecnology
* Corresponding Author Address: Assistant Professor, Department of Biology, Falavarjan Branch, Islamic Azad University, Isfahan, Iran. alinoori55@gmail.com
References
1. Kumar A, Jakhmola A. RNA-mediated fluorescent Q-Pb nanoparticles. Langmuir. 2007; 23(6): 2915-18. doi:10.1021/la0628975
2. Piccinno F, Gottschalk F, Seeger S, Nowack B. Industrial production quantities and uses of ten engineered nanomaterials in Europe and the world. J Nanopart Res. 2012; 14: 1109. doi:10.1007/s11051-012-1109-9
3. Raffa V, Ciofani G, Vittorio O, Riggio C, Cuschieri A. Physicochemical properties affecting cellular uptake of carbon nanotubes. Nanomedicine (Lond). 2010 Jan;5(1):89-97. doi:10.2217/nnm.09.95
4. Cherukuri P, Bachilo SM, Litovsky SH, Weisman RB. Near-infrared fluorescence microscopy of single-walled carbon nanotubes in phagocytic cells. J Am Chem Soc. 2004 Dec;126(48):15638-9. doi:10.1021/ja0466311
5. Stevens RM. New carbon nanotube AFM probe technology. Materials Today, 2009 Oct;12(1): 42-5. https://doi.org/10.1016/S1369-7021(09)70276-7
6. Liu Z, Fan AC, Rakhra K, Sherlock S, Goodwin A, Chen X, et al. Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy. Angew Chem Int Ed Engl. 2009;48(41):7668-72. doi:10.1002/anie.200902612
7. Lee J, Mahendra S, Alvarez PJ. Nanomaterials in the construction industry: a review of their applications and environmental health and safety considerations. ACS Nano. 2010 Jul;4(7):3580-90. doi:10.1021/nn100866w
8. Hillegass JM, Shukla A, Lathrop SA, MacPherson MB, Fukagawa NK, Mossman BT. Assessing nanotoxicity in cells in vitro. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 May; 2(3): 219-31. doi:10.1002/wnan.54
9. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol. 2008 Jul;3(7):423-8. doi:10.1038/nnano.2008.111
10. Rajagopalan P, Wudl F, Schinazi RF, Boudinot FD. Pharmacokinetics of a water-soluble fullerene in rats. Antimicrob Agents Chemother. 1996 Oct;40(10):2262-5.
11. Singh R, Pantarotto D, Lacerda L, Pastorin G, Klumpp C, Prato M, et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci U S A. 2006 Feb;103(9):3357-62. doi:10.1073/pnas.0509009103
12. Shvedova AA, Kisin ER, Murray AR, Kommineni C, Castranova V, Fadeel B, Kagan VE. Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes. Toxicol Appl Pharmacol. 2008 Sep;231(2):235-40. doi:10.1016/j.taap.2008.04.018
13. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983 Jun;16(2):109-10.
14. Donaldson K, Murphy FA, Duffin R, Poland CA. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol. 2010; 7(5):1-17. https://doi.org/10.1186/1743-8977-7-5
15. Ali-Boucetta H, Nunes A, Sainz R, Herrero MA, Tian B, Prato M, et al. Asbestos-like pathogenicity of long carbon nanotubes alleviated by chemical functionalization. Angew Chem Int Ed Engl. 2013 Feb;52(8):2274-8. doi:10.1002/anie.201207664
16. Sun B, Wang X, Ji Z, Wang M, Liao YP, Chang CH, et al. NADPH Oxidase-Dependent NLRP3 Inflammasome Activation and its Important Role in Lung Fibrosis by Multiwalled Carbon Nanotubes. Small. 2015 May; 11(17):2087-97. doi:10.1002/smll.201402859
17. Bhattacharya K, Andón FT, El-Sayed R, Fadeel B. Mechanisms of carbon nanotube-induced toxicity: focus on pulmonary inflammation. Adv Drug Deliv Rev. 2013 Dec;65(15):2087-97. doi:10.1016/j.addr.2013.05.012
18. Lacerda L, Ali-Boucetta H, Herrero MA, Pastorin G, Bianco A, Prato M, et al. Tissue histology and physiology following intravenous administration of different types of functionalized multiwalled carbon nanotubes. Nanomedicine (Lond). 2008 Apr;3(2):149-61. doi:10.2217/17435889.3.2.149
19. Jain S, Thakare VS, Das M, Godugu C, Jain AK, Mathur R, et al. Toxicity of multiwalled carbon nanotubes with end defects critically depends on their functionalization density. Chem Res Toxicol. 2011 Nov; 24(11):2028-39. doi:10.1021/tx2003728
20. Wang B, Feng WY, Wang TC, Jia G, Wang M, Shi JW, et al. Acute toxicity of nano- and micro-scale zinc powder in healthy adult mice. Toxicol Lett. 2006 Feb; 161(2):115-23. doi:10.1016/j.toxlet.2005.08.007
21. Georgakilas V, Kordatos K, Prato M, Guldi DM, Holzinger M, Hirsch A. Organic functionalization of carbon nanotubes. J Am Chem Soc. 2002 Feb;124(5):760-1.
22. Smart SK, Cassady AI, Martin DJ. The biocompatibility of carbon nanotubes. Carbon. 2006;44(6): 1034-47. https://doi.org/10.1016/j.carbon.2005.10.011
23. Park MV, Neigh AM, Vermeulen JP, de la Fonteyne LJ, Verharen HW, Briedé JJ, et al. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials. 2011 Dec;32(36):9810-7. doi:10.1016/j.biomaterials.2011.08.085
24. Fadel TR, Sharp FA, Vudattu N, Ragheb R, Garyu J, Kim D, et al. A carbon nanotube-polymer composite for T-cell therapy. Nat Nanotechnol. 2014 Aug;9(8):639-47. doi:10.1038/nnano.2014.154
Send email to the article author


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Poormohammad Matouri Z, Noori A. Effect of multi-wall carbon nanotubes toxicity on kidney function and tissue in rats. J Gorgan Univ Med Sci 2018; 20 (1) :22-28
URL: http://goums.ac.ir/journal/article-1-3273-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 20, Issue 1 (3-2018) Back to browse issues page
مجله دانشگاه علوم پزشکی گرگان Journal of Gorgan University of Medical Sciences
Persian site map - English site map - Created in 0.04 seconds with 35 queries by YEKTAWEB 4660
Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)